References
- American Society of Addiction Medicine. Public Policy Statement on Treatment of Opioid Use Disorder in Correctional Settings. Published online 2020. Accessed June 8, 2022. Available here.
- U.S. Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder. Published online 2021. Accessed June 8, 2022. Available here.
- National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Medication-Assisted Treatment for Opioid Use Disorder. Medications for Opioid Use Disorder Save Lives. (Mancher M, Leshner AI, eds.). National Academies Press (US); 2019. Accessed July 22, 2019. Available here.
- National Commission on Correctional Health Care. Opioid Use Disorder Treatment in Correctional Settings. National Commission on Correctional Health Care. Published 2021. Accessed June 8, 2022. Available here.
- Rich JD, McKenzie M, Larney S, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. The Lancet. 2015;386(9991):350-359. Available here.
- Substance Abuse and Mental Health Services Administration. Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings. Substance Abuse and Mental Health Services Administration (US); 2019. Accessed August 24, 2022. Available here.
- Green TC, Clarke J, Brinkley-Rubinstein L, et al. Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. JAMA Psychiatry. 2018;75(4):405-407. Available here.
- Grella CE, Ostlie E, Scott CK, Dennis ML, Carnevale J, Watson DP. A scoping review of factors that influence opioid overdose prevention for justice-involved populations. Substance Abuse Treatment, Prevention, & Policy. 2021;16(1):19. Available here.
- Strang J, McCambridge J, Best D, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326(7396):959-960. Available here.
- Chang DC, Klimas J, Wood E, Fairbairn N. A Case of Opioid Overdose and Subsequent Death After Medically Supervised Withdrawal: The Problematic Role of Rapid Tapers for Opioid Use Disorder. J Addict Med. 2018;12(1):80-83. Available here.
- Ajazi EM, Dasgupta N, Marshall SW, et al. Revisiting the X: BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis. Journal of Addiction Medicine. Published online December 3, 2021. Available here.
- Vivitrol and Overdose Risk. Published online February 2022. Accessed June 8, 2022.
- Velasquez M, Flannery M, Badolato R, et al. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Addict Sci Clin Pract. 2019;14(1):37. Available here.
- Mital S, Wolff J, Carroll JJ. The relationship between incarceration history and overdose in North America: A scoping review of the evidence. Drug Alcohol Depend. 2020;213:108088. Available here.
- Ranapurwala SI, Shanahan ME, Alexandridis AA, et al. Opioid Overdose Mortality Among Former North Carolina Inmates: 2000-2015. American Journal of Public Health. 2018;108(9):1207-1213. Available here.
- Alkermes Inc. VIVITROL (naltrexone for extended-release injectable suspension) [package insert]. Published online September 2019. Accessed June 8, 2022. Available here.
- National Institutes of Health. Methadone and buprenorphine reduce risk of death after opioid overdose. National Institutes of Health (NIH). Published June 19, 2018. Accessed June 8, 2022. Available here.
- Wakeman SE, Larochelle MR, Ameli O, et al. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Network Open. 2020;3(2):e1920622. Available here.
- Legal Action Center. Cases Involving Discrimination Based on Treatment with Medication for Opioid Use Disorder (MOUD). Published online June 6, 2022. Accessed June 8, 2022. Available here.
- National Association of Counties. Resolution to Amend the Medical Inmate Exclusion Policy in the Federal Social Security Act. Published online July 12, 2021. Accessed June 8, 2022. Available here.
- U.S. Drug Enforcement Administration. DEA Finalizes Measures to Expand Medication-Assisted Treatment. DEA United States Drug Enforcement Administration. Published June 2021. Accessed June 8, 2022. Available here.
- El-Sabawi T, Baney M, Canzater SL, Weizman S. The New Mobile Methadone Rules And What They Mean For Treatment Access | Health Affairs Forefront. Health Affairs. Published August 4, 2021. Accessed June 8, 2022. Available here.
- Carroll JJ, Asher A, Krishnasamy V, Dowell D. Linking People with Opioid Use Disorder to Medication Treatment. Published online 2022. Accessed June 8, 2022. Available here.
- Prendergast ML, Hall EA, Grossman J, et al. Effectiveness of Using Incentives to Improve Parolee Admission and Attendance in Community Addiction Treatment. Crim Justice Behav. 2015;42(10):1008-1031. Available here.
- Dunphy C, Peterson C, Zhang K, Jones CM. Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder? Drug Alcohol Depend. 2021;225:108784. Available here.
- McClellan C, Moriya A, Simon K. Users of retail medications for opioid use disorders faced high out-of-pocket prescription spending in 2011-2017. J Subst Abuse Treat. 2022;132:108645. Available here.
- Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters. Addiction. 2021;116(12):3473-3481. Available here.
- McKenzie M, Nunn A, Zaller ND, Bazazi AR, Rich JD. Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. J Opioid Manag. 2009;5(4):219-227. Available here.
- Vestal C. At Rikers Island, a Legacy of Medication-Assisted Opioid Treatment. Pew Charitable Trusts. Published May 23, 2016. Accessed January 3, 2019. Available here.
- Leonard N. Inmates first in state to get mobile methadone program. Courier-Post. Published August 2017. Accessed June 8, 2022. Available here.
- King S. An escalated defense: Sheriff Karl Leonard unveils SMART program to treat inmates' opioid addiction. Published May 25, 2022. Available here.
- Advocates for Human Potential. Jail MAT Begins with Immediate Clinical Intake. YouTube. September 30, 2021. Available here.
Related News
Related Resources
Upcoming Events
More From
-
Opioid Solutions Center
NACo’s Opioid Solutions Center empowers local leaders to invest resources in effective treatment, recovery, prevention and harm reduction practices that save lives and address the underlying causes of substance use disorder.
Learn More